Lysophosphatidic Acid Signaling in Cancer
This Special Issue aims to highlight the impact of discoveries made over the last 25 years on the role of autotaxin (ATX) and lysophosphatidic acid (lysophosphatidate, LPA) signaling in tumor growth, metastasis and the treatment of cancers by chemotherapy, radiotherapy and immunotherapy [...]
Main Author: | David N. Brindley |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3791 |
Similar Items
-
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer
by: Eleanna Kaffe, et al.
Published: (2019-10-01) -
Lysophosphatidic Acid Signaling in Diabetic Nephropathy
by: Jong Han Lee, et al.
Published: (2019-06-01) -
LYSOPHOSPHATIDIC ACID PRODUCTION AND SIGNALING IN PLATELETS
by: Fulkerson, Zachary Bennett
Published: (2011) -
Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer
by: David N. Brindley, et al.
Published: (2020-08-01) -
Autotaxin–Lysophosphatidic Acid Signaling in Alzheimer’s Disease
by: Sindhu Ramesh, et al.
Published: (2018-06-01)